Kwivik Therapeutics Inc
Frisco
About Kwivik Therapeutics Inc
Kwivik Therapeutics Inc. is a pre-IPO medtech leader that has developed a novel way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this "oxygen from powder" technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of novel products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding a remarkable $750 Billion.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Private Equity
- Last round: Private Equity (Oct 2018)
- Website: kwivikmedical.com
- Phone: 9727523400
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Internet of Things, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/kwivik-therapeutics-inc-107041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.